ADMA Biologics ADMA Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's cash provided by (used in) operating activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's cash provided by (used in) operating activity, including discontinued operation?
- ADMA Biologics (ADMA) reported cash provided by (used in) operating activity, including discontinued operation of $58.25M in Q1 2026.
- How has ADMA Biologics's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- ADMA Biologics's cash provided by (used in) operating activity, including discontinued operation increased by 396.1% year-over-year, from -$19.68M to $58.25M.
- What is the long-term trend for ADMA Biologics's cash provided by (used in) operating activity, including discontinued operation?
- Over 4 years (2021 to 2025), ADMA Biologics's cash provided by (used in) operating activity, including discontinued operation has grown at a -18.2% compound annual growth rate (CAGR), from -$112.37M to $50.4M.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.